Form 4: Clover Health CEO Andrew Toy Reports Stock Tax Withholding

Clover Health CEO Andrew Toy disposed of 60,765 shares of Class A Common Stock to satisfy tax obligations related to RSU vesting.

Summary

• Andrew Toy, CEO of Clover Health Investments, Corp., reported the disposition of 60,765 shares of Class A Common Stock.
• The transaction occurred on April 15, 2026, at a price of $2.04 per share.
• The shares were withheld by the company to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
• Following this transaction, the reporting person maintains beneficial ownership of 10,009,005 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative action related to executive compensation rather than a strategic shift or market-driven sale.

Positives

• The transaction was a routine tax withholding event rather than a discretionary open-market sale, indicating continued long-term alignment with company performance.

Negatives

• The transaction results in a reduction of the CEO's direct share ownership by 60,765 shares.

Risks

• Continued reliance on RSU vesting schedules for executive compensation may lead to periodic tax-related share dispositions.

Future Outlook

The remaining RSUs are scheduled to vest in equal quarterly installments of 6.25% through October 15, 2028, subject to continued service.

Management Comments

• The transaction represents shares automatically withheld to cover tax obligations due to the vesting of 6.25% of the original RSU grant.

Industry Context

StockSavvy.ai notes that automatic tax withholding upon RSU vesting is a standard corporate governance practice for public companies, ensuring executives meet tax liabilities without requiring discretionary market sales.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation.
• The use of 'sell-to-cover' or withholding shares for taxes is consistent with practices at other healthcare technology firms like Oscar Health or Teladoc.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.

Next Steps

• Continued quarterly vesting of remaining RSU tranches through October 2028.

Key Dates

Keywords

Clover Health, CLOV, Andrew Toy, Form 4, Insider Trading, Stock Withholding, Executive Compensation